CLINICAL_TRIALS
trial_result
· 2024-03-01
Clinical Trial Update: A Study of Hemay005 in Adult With Atopic Dermatitis [Phase 2]
Summary
A Phase 2 trial update for Hemay005 in adults with atopic dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: Hemay005, Atopic Dermatitis | Phase 2 | Status: COMPLETED